Clinical global impression scale
Item
participants with clinical global impression-severity (cgi-s) score greater than or equal to 4 points (moderately ill) at screening
boolean
C3639708 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Contraceptives, Oral | Contraceptive injection | Intrauterine Devices | Barrier Contraception Double | Contraceptive patch
Item
childbearing potential women who consent to the consistent use of the acceptable contraception (oral contraceptive, contraceptive injection, intrauterine device, double barrier method and contraceptive patch)
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0009905 (UMLS CUI [2])
C1656586 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0004764 (UMLS CUI [5,1])
C0205173 (UMLS CUI [5,2])
C2985284 (UMLS CUI [6])
Questionnaire Completion
Item
participants who are capable of and willing to fill out the questionnaire for themselves
boolean
C0034394 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
Compliance behavior Self Medication | Ability Receive Support
Item
participants who are compliant with self-medication or can receive consistent help or support
boolean
C1321605 (UMLS CUI [1,1])
C0036600 (UMLS CUI [1,2])
C0085732 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
C1521721 (UMLS CUI [2,3])
Schizophrenia
Item
have schizophrenia diagnosis by diagnostic and statistical manual of mental disorders, fourth edition (dsm-iv)
boolean
C0036341 (UMLS CUI [1])
Neuroleptic Malignant Syndrome
Item
participants with the past history of neuroleptic malignant syndrome (nms)
boolean
C0027849 (UMLS CUI [1])
Resistant to Therapeutic procedure | Antipsychotic Agents Quantity failed
Item
participants with treatment resistance history who have failed to be properly treated with more than two other kinds of antipsychotic agents (at least 4 weeks of the therapeutic dose administration)
boolean
C0332325 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0040615 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
Gastrointestinal stenosis Severe | Gastrointestinal stenosis Severe Iatrogenic | Lacking Able to swallow Investigational New Drugs
Item
participants with severe (pathologic or iatrogenic) gastrointestinal stenosis or participants who can not swallow the drug whole (the study drug must not be chewed, divided, melted or grinded because it can impact the study drug release profile.)
boolean
C0521587 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0521587 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0439669 (UMLS CUI [2,3])
C0332268 (UMLS CUI [3,1])
C2712086 (UMLS CUI [3,2])
C0013230 (UMLS CUI [3,3])
Exposure to Investigational New Drugs
Item
participants who have been exposed to the study drug within one month before screening
boolean
C0332157 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Risk Significant | At risk for suicide | At risk Aggressive behavior
Item
participants with significant risk including suicide or aggressive behavior
boolean
C0035647 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0563664 (UMLS CUI [2])
C1444641 (UMLS CUI [3,1])
C0001807 (UMLS CUI [3,2])